n-methyl-3,4-methylenedioxyamphetamine has been researched along with Coronary Artery Disease in 1 studies
N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.
Coronary Artery Disease: Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pilgrim, JL | 1 |
| Gerostamoulos, D | 1 |
| Woodford, N | 1 |
| Drummer, OH | 1 |
1 other study available for n-methyl-3,4-methylenedioxyamphetamine and Coronary Artery Disease
| Article | Year |
|---|---|
Serotonin toxicity involving MDMA (ecstasy) and moclobemide.
Topics: Adult; Coronary Artery Disease; Forensic Toxicology; Hallucinogens; Humans; Liver; Lung; Male; Middl | 2012 |